Literature DB >> 15925371

Serum glucose and triglyceride determine high-risk subgroups in non-diabetic postinfarction patients.

James P Corsetti1, Wojciech Zareba, Arthur J Moss, Charles E Sparks.   

Abstract

A strategy was developed to identify subgroups at high risk for recurrent coronary events in non-diabetic postinfarction patients as a function of metabolic, inflammatory, and thrombogenic blood markers. A graphical screening technique for presumptively identifying high-risk subgroups from outcome prevalence maps was devised that was equally sensitive for all values of risk factors in contrast to traditional approaches where risk is presumed for the highest or the lowest values. Traditional statistical analysis confirms high risk in identified subgroups. Serum glucose and triglyceride served as bivariate search domain. Results demonstrated three high-risk subgroups. One was characterized as pre-diabetic; another as metabolic syndrome-enriched; and the third, with unexpectedly high risk, as normoglycemic and modestly hypertriglyceridemic. Within-subgroup risk as determined by Cox proportional hazards model gave for odds ratios and 95 percentile confidence intervals: glucose, 2.49 (1.17-5.33) in pre-diabetic; PAI-1, 3.95 (1.81-8.61) in metabolic syndrome-enriched; and BMI, 2.79 (1.17-6.63) and fibrinogen, 2.79 (1.29-6.04) in normoglycemic, modestly hypertriglyceridemic patients. We conclude that the graphical approach holds promise in screening for high-risk patient subgroups. Finding different within-subgroup predictors of risk underscores the notion of context-dependent risk, an observation that may be relevant for determining optimal use of emerging risk factors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15925371     DOI: 10.1016/j.atherosclerosis.2005.03.046

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  5 in total

1.  Cholesteryl ester transfer protein polymorphism (TaqIB) associates with risk in postinfarction patients with high C-reactive protein and high-density lipoprotein cholesterol levels.

Authors:  James P Corsetti; Dan Ryan; David L Rainwater; Arthur J Moss; Wojciech Zareba; Charles E Sparks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-05-20       Impact factor: 8.311

2.  Reactive Oxygen Species, SUMOylation, and Endothelial Inflammation.

Authors:  Nhat-Tu Le; James P Corsetti; Janet L Dehoff-Sparks; Charles E Sparks; Keigi Fujiwara; Jun-Ichi Abe
Journal:  Int J Inflam       Date:  2012-09-06

3.  Apolipoprotein A-II influences apolipoprotein E-linked cardiovascular disease risk in women with high levels of HDL cholesterol and C-reactive protein.

Authors:  James P Corsetti; Stephan J L Bakker; Charles E Sparks; Robin P F Dullaart
Journal:  PLoS One       Date:  2012-06-18       Impact factor: 3.240

4.  Plasminogen activator inhibitor-2 polymorphism associates with recurrent coronary event risk in patients with high HDL and C-reactive protein levels.

Authors:  James P Corsetti; Peter Salzman; Dan Ryan; Arthur J Moss; Wojciech Zareba; Charles E Sparks
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

5.  Data in support of a central role of plasminogen activator inhibitor-2 polymorphism in recurrent cardiovascular disease risk in the setting of high HDL cholesterol and C-reactive protein using Bayesian network modeling.

Authors:  James P Corsetti; Peter Salzman; Dan Ryan; Arthur J Moss; Wojciech Zareba; Charles E Sparks
Journal:  Data Brief       Date:  2016-05-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.